News

Filter

Current filters:

Regulation

176 to 185 of 96597 results

Oxford BioMedica enters LentiVector collaboration with Novartis

Oxford BioMedica enters LentiVector collaboration with Novartis

10-10-2014

UK-based Oxford BioMedica says that it has signed further contracts with Swiss pharma giant Novartis,…

GlobalLentiVectorLicensingMergers & AcquisitionsNovartisOncologyOxford BioMedicaPharmaceutical

Biogen Idec files for Elocta approval in Europe

Biogen Idec files for Elocta approval in Europe

10-10-2014

US biotech firm Biogen Idec has submitted a Marketing Authorization Application (MAA) for Elocta (rFVIIIFc;…

Biogen IdecBiotechnologyEloctaEloctateEuropeHematologyRegulationSwedish Orphan Biovitrum

Novartis' secukinumab shows strong efficacy in psoriasis Phase III trials

Novartis' secukinumab shows strong efficacy in psoriasis Phase III trials

10-10-2014

Swiss drug major Novartis has reported data from a Phase III trial showing consistent efficacy in clearing…

DermatologicalsNovartisPharmaceuticalResearchsecukinumabSwitzerland

Biotron Phase II trial of BIT225 shows undetectable levels of hepatitis C 12 weeks after finishing treatment

Biotron Phase II trial of BIT225 shows undetectable levels of hepatitis C 12 weeks after finishing treatment

10-10-2014

All hepatitis C genotype 3 patients in a Phase II trial of BIT225, developed by Australian drug developer…

AustraliaBiotechnologyBiotronBIT225Nephrology and HepatologyResearch

DelMar's lead compound VAL-083 data shows potential to be superior to current treatments in NSCLC

DelMar's lead compound VAL-083 data shows potential to be superior to current treatments in NSCLC

10-10-2014

Clinical stage oncology company DelMar Pharmaceuticals’ lead drug compound VAL-083 has demonstrated…

BiotechnologyDelMar PharmaceuticalsOncologyResearchUSAVAL-083

US Congressmen investigate “staggering price increases” for generic drugs

US Congressmen investigate “staggering price increases” for generic drugs

10-10-2014

Letters have been sent to 14 drug manufacturers, including several major Indian firms, requesting information…

GenericsPoliticsPricingUSA

Impax Labs goes on a $700 million buying spree

Impax Labs goes on a $700 million buying spree

09-10-2014

US generic drugmaker Impax Laboratories saw its shares leap 11.2% to $26.52 in pre-market trading today,…

Amedra PharmaceuticalsCorePharmaGenericsImpax LaboratoriesLineage TherapeuticsMergers & AcquisitionsTaiwanUSA

176 to 185 of 96597 results

Back to top